Market Cap : 158.99 B | Enterprise Value : 189.62 B | PE Ratio : 24.74 | PB Ratio : 4.87 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bristol-Myers Squibb Co's book value per share for the quarter that ended in Jun. 2022 was $15.27.
During the past 12 months, Bristol-Myers Squibb Co's average Book Value Per Share Growth Rate was -7.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 24.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Bristol-Myers Squibb Co was 33.60% per year. The lowest was -7.00% per year. And the median was 4.20% per year.
Bristol-Myers Squibb Co's current price is $74.46. Its book value per share for the quarter that ended in Jun. 2022 was $15.27. Hence, today's PB Ratio of Bristol-Myers Squibb Co is 4.88.
During the past 13 years, the highest P/B Ratio of Bristol-Myers Squibb Co was 9.54. The lowest was 2.19. And the median was 5.24.
The historical data trend for Bristol-Myers Squibb Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Book Value per Share, along with its competitors' market caps and Book Value per Share data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Book Value per Share distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's Book Value per Share falls into.
Bristol-Myers Squibb Co's Book Value Per Share for the fiscal year that ended in Dec. 2021 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (35,946 | - | 0) | / | 2,153 | |
= | 16.70 |
Bristol-Myers Squibb Co's Book Value Per Share for the quarter that ended in Jun. 2022 is calculated as:
Book Value Per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (32,600 | - | 0) | / | 2,135 | |
= | 15.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenlees Sharon | officer: SVP & Controller | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Meyers Gregory Scott | officer: EVP, Chief Digital & Tech Off. | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Weese Michelle | officer: EVP, Corporate Affairs | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Hidalgo Medina Manuel | director | BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 |
Rice Derica W | director | 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Mily Elizabeth | officer: EVP, Strategy & BD | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540 |
Metcalfe Kathryn | officer: EVP, Corporate Affairs | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Vessey Rupert | officer: Pres., Research & Early Dev. | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Elkins David V | officer: EVP, Chief Financial Officer | C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Yale Phyllis R | director | |
Ahmed Nadim | officer: President, Hematology | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
From GuruFocus
Other Sources
By Fool 2022-03-30
By tipranks.com 2022-03-21
By Zacks 2022-03-25
By Zacks 2022-03-21
By Zacks 2022-03-25
By Zacks 2022-03-29
By Zacks 2022-03-31
By Zacks 2022-03-23
By Zacks 2022-03-16
By Zacks 2022-03-15
By Zacks 2022-03-21
By Zacks 2022-04-04
By Zacks 2022-03-29
By Fool 2022-03-31